Want to join the conversation?
U.S. weapons maker $LMT said the company achieved a record level of backlog of approx. $100Bil; excluding the acquired Sikorsky backlog, rest of the portfolio achieved $84Bil in backlog, surpassing the $80Bil goal outlined at beginning of 2015. Generated cash from operations of over $5Bil in 2015.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.